CXCL13 and neoplasm: All in all, these results highlighted the relevance of the expression of chemokines such as CXCL13 and the lack of expression of the transmembrane oncoprotein MUC-1 as surrogate markers of the anti-tumor immune response mediated by activated lymphocytes in the TME.